Target Audience and Goal Statement
This activity is intended for electrophysiologists, interventional cardiologists, cardiac surgeons, clinical cardiologists,
cardiology nurses, nurse practitioners, and other allied healthcare professionals.
The goal of this activity is to reinforce the risk for sudden cardiac death among patients with reduced ejection fraction
undergoing revascularization.
Upon completion of this activity, participants will be able to:
- Discuss the mortality risks and risk for sudden cardiac arrest for patients immediately after undergoing percutaneous coronary
intervention (PCI)
- Formulate management plans for patients at risk for sudden cardiac death after undergoing PCI
Disclosures
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of
an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant
financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial
relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food
and Drug Administration, at first mention and where appropriate in the content.
Author(s)

-
Sunil V. Rao, MD
Assistant Professor of Medicine, Duke University Medical Center; Director, Cardiac Catheterization Laboratories, Durham VA
Medical Center, Durham, North Carolina
Disclosures
Disclosure: Sunil V. Rao, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca Pharmaceuticals LP; Lilly; Terumo Medical Corporation; The Medicines Company
Received grants for clinical research from: Ikaria, Inc.; Sanofi
Dr Rao does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
Dr Rao does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

-
James B. Hermiller, MD
Director, Interventional Cardiology, St. Vincent Hospital, Indianapolis, Indiana
Disclosures
Disclosure: James B. Hermiller, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Abbott Laboratories; Boston Scientific; Medtronic, Inc.; St. Jude Medical
Served as a speaker or a member of a speakers bureau for: Lilly; The Medicines Company
Dr Hermiller does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
Dr Hermiller does intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.
Editor
Steering Committee
-
Deepak L. Bhatt, MD, MPH
Chief of Cardiology, VA Boston Healthcare System; Senior Physician, Brigham and Women's Hospital; Professor of Medicine, Harvard
Medical School; Senior Investigator, TIMI Study Group, Boston, Massachusetts
Disclosures
Disclosure: Deepak L. Bhatt, MD, MPH, has disclosed the following relevant financial relationships:
Received grants for clinical research from: AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb Company; Eisai Inc.; Ethicon,
Inc.; Medtronic, Inc.; sanofi-aventis; The Medicines Company; Medtronic, Inc.
-
Roberta C. Bogaev, MD
Assistant Professor of Medicine, Baylor College of Medicine, Houston, Texas; Private Practice Cardiologist, Schnitzler Cardiovascular
Consultants, San Antonio, Texas
Disclosures
Disclosure: Roberta C. Bogaev, MD, has disclosed no relevant financial relationships.
-
Jagmeet P. Singh, MD, PhD
Associate Professor of Medicine, Cardiac Arrhythmia Service, Massachusetts General Hospital Heart Center, Harvard Medical
School, Boston, Massachusetts
Disclosures
Disclosure: Jagmeet P. Singh, MD, PhD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: BIOTRONIK; Boston Scientific; Medtronic, Inc.; St. Jude Medical; Sorin Group; CardioInsight
Technologies Inc.; Thoratec Corporation
Served as a speaker or a member of a speakers bureau for: BIOTRONIK; Boston Scientific; St. Jude Medical; Sorin Group
Received grants for clinical research from: BIOTRONIK; Boston Scientific; St.
CME Reviewer
CE Reviewer
Nurse Planner
-
Laurie E. Scudder, DNP, NP
Nurse Planner, Continuing Professional Education Department, Medscape, LLC; Clinical Assistant Professor, School of Nursing
and Allied Health, George Washington University, Washington, DC
Disclosures
Disclosure: Laurie E. Scudder, DNP, NP, has disclosed no relevant financial relationships.
Accreditation Statements
For Physicians
-
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical
education for physicians.
Medscape, LLC designates this enduring material for a maximum of 0.25
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
Contact This Provider
For Nurses
-
Medscape, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission
on Accreditation.
Awarded 0.25 contact hour(s) of continuing nursing education for RNs and APNs; 0.25 contact hours are in the area of pharmacology.
Contact This Provider
For questions regarding the content of this activity, contact the
accredited provider for this CME/CE activity noted above. For technical
assistance, contact [email protected]
Instructions for Participation and Credit
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
- Read the target audience, learning objectives, and author disclosures.
- Study the educational content online or printed out.
- Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated
at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.